| Basic Information | |
|---|---|
| Species | Zea mays |
| Cazyme ID | GRMZM2G113245_T01 |
| Family | GT47 |
| Protein Properties | Length: 429 Molecular Weight: 48278.8 Isoelectric Point: 9.4936 |
| Chromosome | Chromosome/Scaffold: 9 Start: 154779654 End: 154782133 |
| Description | FRA8 homolog |
| View CDS | |
| External Links |
|---|
| NCBI Taxonomy |
| CAZyDB |
| Signature Domain Download full data set without filtering | |||
|---|---|---|---|
| Family | Start | End | Evalue |
| GT47 | 74 | 369 | 0 |
| VRIYVYDLPARFNRDWAVADARCARHLFAAEVAVHEALLAYTGRAARPEDADLFFVPVYVSCNFSTPNGFPSLSHARGMLADAVDLVQAGMPYWNRSAGA DHVFVASHDFGACFHPMEDVAIADGIPEFLKRSILLQTFGVQGHHTCQEVEHVVIPPHVPPEVEHELPEPEKAQRDIFAFFRGKMEVHPKNISGRFYSKK VRTELLQHYGRNRKFYLKRKRFDNYRSEMARSLFCLCPLGWAPWSPRLVESVLLGCIPVIIADNIRMPFPSVLQWPEISLQVAEKDVANLEVVLDH | |||
| Full Sequence |
|---|
| Protein Sequence Length: 429 Download |
| MGDPRPRRSP AAPTLADKLR KHSTWLLLLL WFAVSLALFL SATPPAAAPL RRSSFLRSKP 60 RALAATGAAA APPVRIYVYD LPARFNRDWA VADARCARHL FAAEVAVHEA LLAYTGRAAR 120 PEDADLFFVP VYVSCNFSTP NGFPSLSHAR GMLADAVDLV QAGMPYWNRS AGADHVFVAS 180 HDFGACFHPM EDVAIADGIP EFLKRSILLQ TFGVQGHHTC QEVEHVVIPP HVPPEVEHEL 240 PEPEKAQRDI FAFFRGKMEV HPKNISGRFY SKKVRTELLQ HYGRNRKFYL KRKRFDNYRS 300 EMARSLFCLC PLGWAPWSPR LVESVLLGCI PVIIADNIRM PFPSVLQWPE ISLQVAEKDV 360 ANLEVVLDHV VATNLSVIQK NLWDPVKRKA LVFNRPMEVG DATWQVLREL EVLLDQSQRR 420 RYGGSWRA* 480 |
| Functional Domains Download unfiltered results here | ||||||||
|---|---|---|---|---|---|---|---|---|
| Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
| pfam03016 | Exostosin | 2.0e-54 | 72 | 367 | 302 | + Exostosin family. The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear. | ||
| Gene Ontology | |
|---|---|
| GO Term | Description |
| GO:0016020 | membrane |
| Annotations - NR Download unfiltered results here | |||||||
|---|---|---|---|---|---|---|---|
| Source | Hit ID | E-Value | Query Start | Query End | Hit Start | Hit End | Description |
| GenBank | AAN62780.1 | 0 | 2 | 427 | 5 | 448 | Unknown protein [Oryza sativa Japonica Group] |
| GenBank | ACN31903.1 | 0 | 1 | 428 | 1 | 428 | unknown [Zea mays] |
| RefSeq | NP_001048697.1 | 0 | 2 | 427 | 5 | 426 | Os03g0107900 [Oryza sativa (japonica cultivar-group)] |
| RefSeq | NP_197685.2 | 0 | 24 | 421 | 48 | 458 | F8H (FRA8 HOMOLOG); catalytic [Arabidopsis thaliana] |
| RefSeq | XP_002468679.1 | 0 | 1 | 427 | 1 | 428 | hypothetical protein SORBIDRAFT_01g050110 [Sorghum bicolor] |
| Metabolic Pathways | |||
|---|---|---|---|
| Pathway Name | Reaction | EC | Protein Name |
| xylogalacturonan biosynthesis | RXN-9589 | EC-2.4.2.41 | xylogalacturonan β-1,3-xylosyltransferase |
